Topicus Healthcare: Organic Growth Case Study
Former Managing Director at Topicus
inpractise.com/articles/topicus-healthcare-organic-growth-tools
Topicus Healthcare: Organic Growth Case Study(June 2, 2024)
Former Managing Director at Topicus
The executive is a Former Managing Director for an operating company within Topicus Healthcare division.
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Yes, but everyone says that Topicus is the golden child for organic growth when you read CSI. They praise how good they are at it. Are they really that good, and if so, why?
They are quite good at it. However, I think they could leverage it much more. They could achieve much higher margins. Initially, they started with three shareholders, all of whom enjoyed buying software and building the company. They all had a technical engineering background. The three owners, Henk Jan, Harry Romkema, and the other individual, were very naive initially. This naivety led them to invest heavily in specific verticals. They were aligned, and they didn't have shareholders or private equity, which often complicates matters. They had deep pockets in sectors where it's very difficult for new market players to enter. They quickly understood this and chose the right domains and sectors to invest in heavily. This strategy gave them an advantage over other companies that didn't have these deep resources but wanted higher margins. This is how they developed these verticals.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.